ACE2 and metabolic syndrome: Recently, ACE2 polymorphisms were analyzed in the human, and it was proposed that ACE2 expression could impact the susceptibility of people to cardiovascular disease, hypertension, dyslipidemia, diabetes, and SARS-CoV-2 infection [32].